Company Filing History:
Years Active: 1999
Title: The Innovations of Thomas F DeKoning
Introduction
Thomas F DeKoning is an accomplished inventor based in Marcellus, MI (US). He has made significant contributions to the field of medicine, particularly in the area of angiogenesis. His work focuses on developing steroids that can inhibit angiogenesis, which is crucial for treating various diseases.
Latest Patents
Thomas F DeKoning holds a patent for "Steroids which inhibit angiogenesis - Novel angiostatic Δ4,9(11)-steroids." This patent describes the use of C21-oxygenated steroids and other known steroidal compounds in treating angiogenesis in mammals. These steroids have shown potential in addressing diseases related to neovascularization, such as cancer, diabetes, and arthritis. He has 1 patent to his name.
Career Highlights
DeKoning is currently associated with Alcon Laboratories, Inc., where he continues to innovate and contribute to advancements in medical treatments. His work has been instrumental in exploring new therapeutic avenues for serious health conditions.
Collaborations
Throughout his career, Thomas has collaborated with notable colleagues, including John W Wilks and Paul A Aristoff. These partnerships have enhanced the research and development of his innovative ideas.
Conclusion
Thomas F DeKoning's contributions to the field of medicine through his innovative patents highlight the importance of research in combating serious diseases. His work continues to inspire advancements in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.